Workers' Compensation for Psychedelic-Assisted Therapy in Canada

For injured workers with compensable PTSD (post-traumatic stress disorder), TRD (treatment-resistant depression), or chronic pain, provincial workers' compensation boards provide the most established Canadian coverage pathway for ketamine therapy specifically. WSIB (Ontario's Workplace Safety and Insurance Board) lists ketamine and esketamine on multiple specialty formularies (Psychotraumatic, Serious Injury, Musculoskeletal, CNS/PNS, Chronic Pain Disability) with prior authorization. WCB (Workers' Compensation Board) Alberta has a documented Pharmaceutical Ketamine and Esketamine procedure covering compensable CRPS (Complex Regional Pain Syndrome), refractory neuropathic pain, and (under Bill 30) presumptive PTSD for first responders. WorkSafeBC reviews case-by-case with cautious Evidence-Based Practice Group reviews. CNESST (Commission des normes, de l'équité, de la santé et de la sécurité du travail) Quebec, WCB Manitoba, WCB Saskatchewan, and WCB Nova Scotia review case-by-case without formal listings. Psilocybin and MDMA are not formally listed on any Canadian workers' compensation formulary at this time — case-by-case review may apply for compensable PTSD, but is uncommon. Presumptive PTSD legislation in Ontario (Bill 163, expanded October 2024) and Alberta (Bill 30) accelerates eligibility for designated first responders. This article walks through the cross-substance Canadian workers' compensation pathway honestly.

Key takeaways

• WSIB Ontario lists ketamine and esketamine on 5 specialty formularies (Psychotraumatic, Serious Injury, Musculoskeletal, CNS/PNS, Chronic Pain Disability) with prior authorization.
• WCB Alberta has a documented Pharmaceutical Ketamine and Esketamine procedure — covers compensable CRPS, refractory neuropathic pain, presumptive PTSD for first responders.
• WorkSafeBC reviews case-by-case; Evidence-Based Practice Group has published cautious reviews on IV/oral ketamine for chronic non-cancer pain.
• CNESST Quebec, WCB Manitoba, WCB Saskatchewan, WCB Nova Scotia: case-by-case without formal listings.
• Presumptive PTSD legislation — Ontario Bill 163 (expanded Oct 2024) and Alberta Bill 30 — accelerates underlying PTSD eligibility for designated first responders but does NOT auto-approve specific treatments.
• Psilocybin and MDMA: NOT formally listed on any Canadian workers' compensation formulary. Case-by-case review may apply.
• Designated first responders (Ontario Bill 163, expanded Oct 2024): firefighters, police, paramedics, nurses, 911 dispatchers, corrections officers, wildland firefighters, wildland fire investigators.
• ATMA CENA's role: supports preparation and integration via coordinated care for compensable workers in coordination with WSIB/WCB-affiliated physicians.

WSIB Ontario — multiple specialty formularies

WSIB Ontario provides the most comprehensive Canadian workers' compensation coverage for ketamine. The framework lists ketamine and esketamine on five specialty formularies with prior authorization for compensable injuries:

The five formularies

1. Psychotraumatic (22WS) — for compensable PTSD, including first-responder presumptive PTSD under Bill 163
2. Serious Injury (27WS) — for serious-injury claims with comorbid PTSD or chronic pain
3. Musculoskeletal — for compensable musculoskeletal pain conditions
4. CNS/PNS (Central Nervous System / Peripheral Nervous System) — for nervous system injury pain
5. Chronic Pain Disability — for chronic pain disability claims

The five-formulary framework reflects the cross-indication evidence base for ketamine: PTSD, TRD, chronic pain, neuropathic pain, and compensable serious injury all have varying evidence support and are mapped to specific formularies based on clinical context.

For the WSIB Ontario formulary detail: WSIB Ontario — Drug Formulary Listing Decision: Ketamine and Esketamine.

Bill 163 — presumptive PTSD for designated first responders

Ontario's Bill 163 (passed 2016, expanded October 2024) provides presumptive PTSD coverage for designated first responders. The October 2024 expansion added wildland firefighters and wildland fire investigators to the existing list:

• Firefighters (municipal, professional, volunteer)
• Police officers
• Paramedics
• Nurses (in certain settings)
• 911 dispatchers / emergency-response telephone operators
• Corrections officers
• Wildland firefighters and wildland fire investigators (added October 2024)

Under presumptive PTSD legislation:

• Workers no longer have to prove the PTSD is work-related to access WSIB benefits
• The presumption shifts the burden of proof to WSIB if they wish to deny on causation grounds
• The underlying PTSD diagnosis is accelerated, which speeds access to mental-health treatment broadly

However, presumptive PTSD does not auto-approve specific treatments. WSIB still applies prior-authorization criteria for ketamine, esketamine, and other formulary listings. Case-by-case clinical justification is required.

For the full WSIB Ontario PTSD policy: WSIB Ontario — Posttraumatic Stress Disorder First Responders and Other Designated.

Practical WSIB Ontario application sequence

1. Establish compensable diagnosis with WSIB (presumptive PTSD for designated first responders accelerates this)
2. Identify a prescribing physician willing to provide ketamine therapy
3. Document conventional treatment failures appropriate to the indication
4. Submit prior-authorization request for the specific ketamine formulary listing
5. WSIB review — typically several weeks
6. If approved: treatment delivered with WSIB reimbursement

Psilocybin and MDMA on WSIB

Not formally listed. Case-by-case review may apply for compensable PTSD, but volume is low. The realistic 2026 WSIB pathway for PTSD remains ketamine/esketamine specifically.

For more detail on ketamine therapy: Ketamine Therapy for PTSD, Ketamine Therapy for Chronic Pain.

WCB Alberta — documented procedure

WCB Alberta has a documented Pharmaceutical Ketamine and Esketamine procedure. Coverage scope:

• Compensable CRPS (Complex Regional Pain Syndrome) — strongest pain evidence
• Compensable refractory neuropathic pain
• Compensable PTSD under Bill 30 presumptive coverage for designated first responders

For the WCB Alberta procedure document: WCB Alberta — Pharmaceutical Ketamine and Esketamine.

Bill 30 (Workers' Compensation Amendment Act, 2018) — Alberta presumptive PTSD

Alberta's Bill 30 (Workers' Compensation Amendment Act, 2018) establishes presumptive PTSD coverage for designated first responders, similar in architecture to Ontario's Bill 163. Designated occupations include firefighters, police, paramedics, corrections officers, and other first-responder roles.

Under Bill 30 presumptive PTSD:

• Accelerated underlying PTSD eligibility without proving work-relatedness
• Specific ketamine prior authorization still applies — case-by-case clinical justification required
• Coordination with provincial regulator standards (CPSA Alberta NSHF accreditation for IV ketamine; CPSA Ketamine Clinical Toolkit)

Psilocybin and MDMA on WCB Alberta

Not formally listed. Case-by-case review may apply for compensable PTSD; uncommon.

WorkSafeBC

WorkSafeBC reviews ketamine and other psychedelic-assisted therapy claims case-by-case. WorkSafeBC's Evidence-Based Practice Group has published reviews on IV and oral ketamine for chronic non-cancer pain, including a 2025 update. The position is cautious; coverage decisions depend on specific compensable injury, prior treatment, and clinical context.

For the WorkSafeBC review: WorkSafeBC — IV and Oral Ketamine for Chronic Non-Cancer Pain (2025 Update).

BC presumptive PTSD legislation has been advancing through legislative processes; specific coverage acceleration for first responders is in development.

Psilocybin and MDMA: not formally listed.

For BC ketamine therapy context: Ketamine Therapy in Vancouver, Ketamine Therapy in Victoria BC.

CNESST Quebec

CNESST (Commission des normes, de l'équité, de la santé et de la sécurité du travail) is Quebec's workers' compensation body. CNESST reviews ketamine and other psychedelic-assisted therapy claims case-by-case without formal listings comparable to WSIB Ontario.

Quebec service-connected populations potentially eligible for CNESST review:

• Sûreté du Québec (provincial police)
• Municipal police, paramedics, firefighters
• Wildland firefighters
• Other compensable PTSD or chronic pain claims

Quebec's Bill 21 reserved-act psychotherapy affects who can deliver the psychotherapy component of psychedelic-assisted therapy in Quebec — physicians, psychologists, or OPQ permit holders. This applies regardless of CNESST coverage. See Ketamine Therapy in Montreal.

WCB Manitoba, WCB Saskatchewan, WCB Nova Scotia, and other provincial WCBs

Other provincial WCB boards review case-by-case without formal psychedelic-assisted therapy listings comparable to WSIB Ontario or WCB Alberta. The realistic 2026 pathway in these provinces:

• Ketamine prior-authorization may be possible for compensable PTSD or chronic pain on a case-by-case basis
• Psilocybin and MDMA case-by-case review is uncommon
• Provincial presumptive PTSD legislation status varies

How to think about the cross-substance workers' compensation decision

For injured workers with compensable conditions, the practical decision framework:

For compensable PTSD (designated first responders):

• Presumptive legislation accelerates the underlying diagnosis (Ontario Bill 163, Alberta Bill 30, others advancing)
• Ketamine/esketamine is the most accessible covered treatment in Ontario (WSIB) and Alberta (WCB) with formal listings
• MDMA-AT has stronger PTSD-specific RCT evidence but case-by-case workers' compensation review is uncommon
• Psilocybin is not workers' compensation-covered

For compensable chronic pain:

• WSIB Ontario lists ketamine on Musculoskeletal, CNS/PNS, Chronic Pain Disability formularies
• WCB Alberta covers compensable CRPS and refractory neuropathic pain via the pharmaceutical procedure
• Psilocybin and MDMA do not target chronic pain mechanism; not workers' compensation-covered

For compensable serious injury with comorbid mental health:

• WSIB Ontario Serious Injury (27WS) formulary covers complex cases
• Cross-coverage between formularies (Psychotraumatic + Serious Injury + Chronic Pain) supports comprehensive treatment

For the cross-substance decision matrix on PTSD specifically: MDMA vs Ketamine for PTSD.

How ATMA CENA supports compensable patients

ATMA CENA's role for injured workers and first responders pursuing psychedelic-assisted therapy:

• The medical prescription and provincial regulator compliance is the responsibility of the prescribing physician — typically a CPSA (Alberta), CPSO (Ontario), CPSBC (BC), or CMQ (Quebec) registered specialist with appropriate accreditation for the specific clinical setting (e.g., CPSA NSHF for IV ketamine).
• ATMA CENA supports preparation and integration through the three-phase psychedelic-assisted therapy model. For compensable workers, this includes coordinated planning with the patient's WSIB/WCB-affiliated physician, family/spouse involvement where appropriate, and realistic timeline planning.
• The coordinated care model is particularly valuable for first responders with established mental-health-care relationships — including WSIB-affiliated psychologists and EAP-program therapists. The existing therapist can remain primary while ATMA CENA's clinical infrastructure provides the dosing-specific frame.
• ATMA CENA's intake call screens for workers' compensation eligibility during the 15-minute information conversation, helping injured workers map their specific compensable claim to the realistic prior-authorization framework.

Frequently asked questions

Does workers' compensation cover psychedelic-assisted therapy? For ketamine specifically: yes, with established formal pathways at WSIB Ontario (5 specialty formularies) and WCB Alberta (pharmaceutical procedure). WorkSafeBC, CNESST Quebec, and other provincial boards review case-by-case. Psilocybin and MDMA are not formally listed on any Canadian workers' compensation formulary.

What's WSIB Ontario's coverage scope? Ketamine and esketamine on Psychotraumatic (22WS), Serious Injury (27WS), Musculoskeletal, CNS/PNS, and Chronic Pain Disability formularies. Prior authorization required.

What's WCB Alberta's coverage scope? Documented Pharmaceutical Ketamine and Esketamine procedure covering compensable CRPS, refractory neuropathic pain, and Bill 30 presumptive PTSD for first responders.

What's presumptive PTSD legislation? Provincial laws (Ontario Bill 163, Alberta Bill 30, others) that establish a legal presumption that PTSD diagnosed in designated first responders is work-related, accelerating eligibility for workers' compensation benefits. The presumption applies to the underlying PTSD diagnosis; specific treatments still require case-by-case review.

Who's covered under Ontario's Bill 163? Firefighters, police, paramedics, nurses, 911 dispatchers, corrections officers, wildland firefighters, and wildland fire investigators (the latter two added October 2024).

Who's covered under Alberta's Bill 30? Designated first responders including firefighters, police, paramedics, corrections officers, and other first-responder roles.

Does workers' comp cover MDMA-AT for PTSD? Not formally on any Canadian workers' compensation formulary. Case-by-case review may apply for compensable PTSD, but volume is low. The realistic workers' comp-covered PTSD pathway is ketamine/esketamine specifically.

Does workers' comp cover psilocybin? No — not formally listed on any Canadian workers' compensation formulary. Case-by-case review uncommon.

What's the application sequence? Establish compensable diagnosis (presumptive PTSD accelerates this for first responders) → identify prescribing physician → document conventional treatment failures → submit prior-authorization request → WSIB/WCB review → if approved, treatment with reimbursement.

Can I appeal a denied prior auth? Yes. WSIB and WCB boards have appeal processes. Documentation of additional clinical justification, alternative treatment failures, or specialist consultation typically supports appeals. Specialized lawyers and patient advocates assist with complex appeals.

What if I'm not a first responder but have compensable PTSD? Workers in non-first-responder occupations with compensable PTSD can still pursue WSIB/WCB ketamine prior authorization without the presumptive-eligibility acceleration. The case requires more documentation of work-relatedness but is real.

Does WCB cover the therapy fees as well as the drug? Coverage architectures vary. WSIB Ontario typically covers prescribed drugs and may cover physician-prescribed psychotherapy; specific psychotherapy coverage maximums apply. The clinic should be able to map your specific case.

What about EAP (Employee Assistance Program) coverage? EAP programs are separate from workers' compensation and typically provide short-term mental-health support including some psychotherapy. Some EAP programs may cover preparation/integration psychotherapy for psychedelic-assisted therapy as standard psychotherapy. Confirm with your specific EAP provider.

How does workers' comp interact with private insurance? Generally workers' compensation is the primary payer for compensable conditions; private insurance is secondary. Specifics vary by provincial board and plan structure.

Where can I get legal help with my workers' comp claim? Specialized workers' compensation lawyers and patient advocacy organizations exist in each province. WSIB Ontario has the Office of the Worker Adviser; other provinces have similar advocacy resources.

Sources

1. ATMA CENA — find care near you: https://psychedelic.healthcare/find-care
2. WSIB Ontario — Drug Formulary Listing Decision: Ketamine and Esketamine: https://www.wsib.ca/en/drug-formulary-listing-decision-ketamine-and-esketamine
3. WSIB Ontario — Posttraumatic Stress Disorder First Responders Policy: https://www.wsib.ca/en/operational-policy-manual/posttraumatic-stress-disorder-first-responders-and-other-designated
4. Ontario News Release on Bill 163 Expansion (October 2024): https://news.ontario.ca/en/release/36382/ontario-passes-legislation-to-support-first-responders-with-ptsd
5. WCB Alberta — Pharmaceutical Ketamine and Esketamine: https://www.wcb.ab.ca/about-wcb/procedures-manual/pharmaceutical-ketamine-and-esketamine.html
6. WCB Alberta — Presumptive PTSD Coverage Fact Sheet: https://www.wcb.ab.ca/assets/pdfs/employers/EFS_Presumptive_coverage_for_traumatic_psychological_injuries.pdf
7. WorkSafeBC — IV and Oral Ketamine for Chronic Non-Cancer Pain (2025 Update): https://www.worksafebc.com/en/resources/health-care-providers/guides/issues-on-iv-ketamine-and-oral-ketamine-for-chronic-non-cancer-pain-2025-update
8. CNESST Quebec: https://www.cnesst.gouv.qc.ca/
9. Health Canada DPD — Spravato: https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=98903
10. CPSA — Ketamine Clinical Toolkit (Alberta): https://cpsa.ca/resources/ketamine-toolkit/

Related articles

• Insurance Coverage for Psychedelic-Assisted Therapy in Canada
• PSHCP / Canada Life Spravato Coverage
• Alberta Blue Cross PAT Coverage
• VAC Coverage for Psychedelic-Assisted Therapy
• Ketamine Therapy for PTSD
• Ketamine Therapy for Chronic Pain
• MDMA vs Ketamine for PTSD
• Find care near you

Last updated: 2026-05-06